treatment of chronic constipation

SPI Subsidiary Sucampo Pharmaceuticals Received Approval in Japan for Amitiza
Dec 5, 2012
SPI subsidiary Sucampo Pharmaceuticals has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription drug for the treatment of chronic constipation, excluding constipation caused by ...

Tags: amitiza, lubiprostone, treatment of chronic constipation, prostone